Literature DB >> 525186

Bilio-intestinal shunt. A method and a pilot study for treatment of obesity.

D Hallberg, U Holmgren.   

Abstract

Diarrhea is a drawback in all types of small intestinal bypass operations for the treatment of morbid obesity. One of the causes of diarrhea is excessive amounts of bile acids in the colon. Therefore in five obese subjects, we complemented the usual jejuno-ileostomy end to side procedure with an anastomosis between the proximal end of the excluded blind loop and the gallbladder (bilio-intestinal shunt). In this way the enterohepatic circulation of bile acids is assumed to be preserved. The patients, subjected to this new methods, were compared to matched patients (age, sex, height, preoperative body-weight, Brocas index and total small intestinal length) following four other types of jejuno-ileostomies. The frequency of diarrhea in the subjects with the bilio-intestinal shunt was significantly less than in the other groups. Other parameters, such as rate and magnitude of weight reduction, changes in blood cholesterol and triglycerides, were the same in the control groups.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525186

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Ten years of follow-up of bilio-intestinal bypass: is malabsorption necessary for long-term metabolic results?

Authors:  Antonio Vitiello; Pilone Vincenzo; Antonio Formato; Giuliano Izzo; Luca Ferraro; Pietro Forestieri
Journal:  Langenbecks Arch Surg       Date:  2018-10-20       Impact factor: 3.445

Review 2.  Surgical management of morbid obesity.

Authors:  S N Joffe
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

3.  Surgical treatment of massive obesity: our experience with jejunoileal bypass.

Authors:  W Montorsi; S B Doldi
Journal:  World J Surg       Date:  1981-11       Impact factor: 3.352

4.  Gallstone ileus after biliointestinal bypass: report of two cases.

Authors:  Giancarlo Micheletto; Piergiorgio Danelli; Anna Morandi; Valerio Panizzo; Marco Montorsi
Journal:  J Gastrointest Surg       Date:  2013-07-30       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.